Drug combo may help curb bedwetting

By David Douglas

NEW YORK (Reuters Health) - In children who continue to wet the bed despite standard treatment with desmopressin, adding the bladder-control drug tolterodine (Detrol) to therapy leads to a significant decrease in the risk of bedwetting, Missouri-based researchers have found.

Desmopressin, lead researcher Dr. Paul F. Austin told Reuters Health, is the most frequently prescribed medication for bedwetting “and we, along with others, have found that functional bladder capacity is a reliable predictor of response to desmopressin. Children with larger bladders are more likely to exhibit a successful response.”

Therefore, his team sought to see if adding another medicine that increases bladder capacity, like tolterodine, would thereby increase the response to desmopressin.

Accordingly, Austin, of Washington University School of Medicine, St. Louis, and colleagues randomly assigned 41 children who had not responded adequately to desmopressin to continue with the drug in combination with tolterodine or placebo.

After 1 month of treatment and exclusion of 7 “noncompliant” patients, the team found a significant 66 percent reduction in the risk of bedwetting in the combination therapy group.

The combination group also had a higher rate of full or partial response (44 percent) than the placebo group (31 percent). Moreover, only 16.5 percent of patients in the study group had a complete lack of response, compared to 44 percent in the placebo group.

“We showed …. that there was a significant reduction in the mean number of wet nights in the combination therapy group as compared to placebo,” Austin noted.

SOURCE: Pediatrics November 2008.


Related Posts:

NEW YORK (Reuters Health) - The odds are high that a woman who is prescribed an “anticholinergic” drug to relieve urinary incontinence or other lower urinary tract symptom will discontinue the medication not long after starting it, a study suggests. This is true regardless of the class of medication used. Two examples of anticholinergic drugs that

Full Post: Drug adherence poor in women with urinary trouble

By Julie Steenhuysen CHICAGO (Reuters) - The popular antidepressant Lexapro showed promise at easing anxiety symptoms in older adults, but the effect was “modest” and would need to be studied further, U.S. researchers said on Tuesday. They said antidepressants like Lexapro, made by Forest Laboratories Inc and known generically as escitalopram, may be useful as a new

Full Post: Lexapro may ease anxiety in older adults: study

By Joene Hendry NEW YORK (Reuters Health) - Children who are breast fed for at least 4 months may have better lung function than children who are breast fed for shorter periods of time and children who are bottle fed, a new study suggests. Among 10-year old children, researchers found greater lung function and capacity in those

Full Post: Kids’ lungs benefit from longer breast feeding

By Anne Harding NEW YORK (Reuters Health) - Older people taking a sports nutrition supplement favored by Olympic athletes show substantial increases in their ability to withstand fatigue, new research shows. “We were surprised that it had this kind of impact,” Dr. Jeffrey R. Stout of the University of Oklahoma in Norman, who led the study, told

Full Post: Beta-alanine helps seniors stave off fatigue

NEW YORK (Reuters Health) - Patients with a common and painful heel condition called plantar fasciitis benefit from a new type of shock wave therapy in which energy is delivered across a broader area of the foot, German researchers report. The treatment, called radial extracorporeal shock wave therapy (ESWT), “can be strongly recommended for patients with

Full Post: Shock wave therapy relieves plantar fasciitis pain

Site Navigation

Most Read



  • kinwrite.com@gmail.com